PET-Based Radiogenomics Supports mTOR Pathway Targeting for Hepatocellular Carcinoma.
An J, Oh M, Kim SY, Oh YJ, Oh B, Oh JH, Kim W, Jung JH, Kim HI, Kim JS, Sung CO, Shim JH.
An J, et al. Among authors: oh yj, oh m, oh b, oh jh.
Clin Cancer Res. 2022 May 2;28(9):1821-1831. doi: 10.1158/1078-0432.CCR-21-3208.
Clin Cancer Res. 2022.
PMID: 35191466